Select Publications:

mTORC1 regulation of protein synthesis, synaptic tagging, and neuronal excitability:

PMID:28611595

PMID:28493559

PMID:28286470

Niere F*, Namjoshi S*, Song E, Dilly GA, Schoenhard G, Zemelman BV, Mechref Y, Raab-Graham KF.
Analysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC).
Mol Cell Proteomics. 2016 Feb;15(2):426-44. doi: 10.1074/mcp.M115.055079. Epub 2015 Sep 29.

PMID:26419955

*authors contributed equally

Sosanya NM, Cacheaux LP, Workman ER, Niere F, Perrone-Bizzozero NI, Raab-Graham KF.
Mammalian Target of Rapamycin (mTOR) Tagging Promotes Dendritic Branch Variability through the Capture of Ca2+/Calmodulin-dependent Protein Kinase II α (CaMKIIα) mRNAs by the RNA-binding Protein HuD.
J Biol Chem. 2015 Jun 26;290(26):16357-71. doi: 10.1074/jbc.M114.599399. Epub 2015 May 5.

PMID:25944900

One of the top 5 most viewed articles at the Journal of Biological Chemistry in May and June, 2015

Sosanya NM, Brager DH, Wolfe S, Niere F, Raab-Graham KF.
Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis.
Neurobiol Dis. 2015 Jan;73:96-105. doi: 10.1016/j.nbd.2014.09.011. Epub 2014 Sep 28.

PMID:25270294

Sosanya NM, Huang PP, Cacheaux LP, Chen CJ, Nguyen K, Perrone-Bizzozero NI, Raab-Graham KF.
Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1.
J Cell Biol. 2013 Jul 8;202(1):53-69. doi: 10.1083/jcb.201212089.

PMID:23836929

Highlighted in Journal of Cell Biology (Kepert, I. and Kiebler, M.A. (2013) monitTORing neuronal excitability at the synapse, Journal of Cell Biology, 202, 7-9.

Raab-Graham KF*, Haddick PC*, Jan YN, Jan LY.
Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites.
Science. 2006 Oct 6;314(5796):144-8.

PMID:17023663

        *authors contributed equally

Highlighted in Editors’ Choice (Sci. STKE 356:348, 2006)

Highlighted in Previews (Neuron 52:399-401, 2006).

Highlighted in “Highlights from the Literature” (Physiology 21:3-6, 2007)

Underlying mechanisms of rapid antidepressant therapies:

Wolfe SA, Workman ER, Heaney CF, Niere F, Namjoshi S, Cacheaux LP, Farris SP, Drew MR, Zemelman BV, Harris RA, Raab-Graham KF.

PMID: 27666021

Raab-Graham KF, Workman ER, Namjoshi S, Niere F.
Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression.
Brain Res. 2016 Apr 26. pii: S0006-8993(16)30215-3. doi: 10.1016/j.brainres.2016.04.020. [Epub ahead of print] Review.

PMID:27125595

Workman ER, Haddick PC, Bush K, Dilly GA, Niere F, Zemelman BV, Raab-Graham KF.
Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η.
Mol Psychiatry. 2015 Mar;20(3):298-310. doi: 10.1038/mp.2014.165. Epub 2015 Jan 6.

PMID:25560757

Invited Cover

Workman ER, Niere F, Raab-Graham KF.
mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling.
Neuropharmacology. 2013 Oct;73:192-203. doi: 10.1016/j.neuropharm.2013.05.037. Epub 2013 Jun 8.

PMID:23752093